Dementia
By M3 Information · November 19, 2026
About a 2-minute readThe test is not ready for the doctor’s office. What families notice at home still matters.
Alzheimer’s disease involves the buildup of two proteins in the brain, tau and amyloid-beta. Forms of both can be measured in blood. Earlier work tied higher levels to weaker memory in older adults. This study, reported in the September 2026 NIH News in Health, asked whether the same link shows up earlier in life.
It does. Most participants had taken the same thinking and memory tests five years before, so the researchers could compare. Those with more of the Alzheimer’s-related proteins in their blood had declined more. As Dr. Kristine Yaffe of the University of California, San Francisco put it, “Alzheimer’s disease pathology begins years before symptoms emerge.”
For now, nothing changes at the doctor’s office. NIH is clear that the tests need more study first. The value of the finding is the reminder that change starts early and slowly, which is exactly when it is hardest to see.
Small shifts in mood, memory and everyday tasks are easier to spot when someone writes them down on a schedule. The M3 Dementia Review does that at home and produces a record to bring to the next physician visit. It is a record for that conversation, never a diagnosis.
A private record of mood, memory and everyday tasks to bring to your physician. It is informational and is not a diagnosis.
Start a Dementia ReviewSource: NIH News in Health, September 2026, “Blood Tests May Flag Early Alzheimer’s.” More detail in NIH Research Matters.
NIH material is not copyrighted. This post is M3’s summary; NIH has not reviewed or endorsed it. This post is general information, not medical advice. Talk with your doctor about any concerns.
← Back to all articles